Triple
T18386466
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Merck KGaA global headquarters |
E446604
|
entity |
| Predicate | hasTenant |
P3277
|
FINISHED |
| Object | Merck KGaA central corporate functions |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Merck KGaA central corporate functions | Statement: [Merck KGaA global headquarters, hasTenant, Merck KGaA central corporate functions]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Merck KGaA central corporate functions Context triple: [Merck KGaA global headquarters, hasTenant, Merck KGaA central corporate functions]
-
A.
Merck KGaA global headquarters
Merck KGaA global headquarters is the central corporate and administrative hub of the multinational science and technology company Merck KGaA.
-
B.
Merck Life Science
Merck Life Science is the life science business of Merck KGaA, providing products and technologies for research, biotechnology, and pharmaceutical development worldwide.
-
C.
Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
-
D.
Boehringer Ingelheim
Boehringer Ingelheim is a major German research-driven pharmaceutical company known for developing prescription medicines, animal health products, and biopharmaceuticals worldwide.
-
E.
Lonza
Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Merck KGaA central corporate functions Target entity description: Merck KGaA central corporate functions comprise the company’s core administrative, strategic, and management departments that oversee and coordinate its global operations from the headquarters.
-
A.
Merck KGaA global headquarters
chosen
Merck KGaA global headquarters is the central corporate and administrative hub of the multinational science and technology company Merck KGaA.
-
B.
Merck Life Science
Merck Life Science is the life science business of Merck KGaA, providing products and technologies for research, biotechnology, and pharmaceutical development worldwide.
-
C.
Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
-
D.
Boehringer Ingelheim
Boehringer Ingelheim is a major German research-driven pharmaceutical company known for developing prescription medicines, animal health products, and biopharmaceuticals worldwide.
-
E.
Lonza
Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
- F. None of above.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8b9f370b88190b1e5081c2c238e7f |
completed | April 10, 2026, 8:50 a.m. |
| NER | Named-entity recognition | batch_69e517a00c608190a8f0010c7b53df90 |
completed | April 19, 2026, 5:57 p.m. |
Created at: April 10, 2026, 10:46 a.m.